World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
66
Citations
16203
World Ranking
2757
National Ranking
1313

David V. Serreze publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where David V. Serreze sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 238 publications — 47th percentile

47% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

David V. Serreze D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where David V. Serreze sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 66 D-Index — 45th percentile

45% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

David V. Serreze is affiliated with The Jackson Laboratory in the United States. Their research focuses on immunology, microbiology, medicine, and biochemistry, genetics, and molecular biology, with prominent subfields including immunology, genetics, oncology, surgery, and endocrinology, diabetes, and metabolism.

Their work covers several main topics such as diabetes and associated disorders, immune cell function and interaction, T-cell and B-cell immunology, pancreatic function and diabetes, diabetes management and research, CAR-T cell therapy research, and cancer immunotherapy and biomarkers.

Recent publications by David V. Serreze include:

  • "Aberrant type 1 immunity drives susceptibility to mucosal fungal infections," 2021, Science
  • "Decreased pancreatic acinar cell number in type 1 diabetes," 2020, Diabetologia
  • "CD226 Deletion Reduces Type 1 Diabetes in the NOD Mouse by Impairing Thymocyte Development and Peripheral T Cell Activation," 2020, Frontiers in Immunology
  • "Toll-Like Receptor 7 Is Required for Lacrimal Gland Autoimmunity and Type 1 Diabetes Development in Male Nonobese Diabetic Mice," 2020, International Journal of Molecular Sciences
  • "The CD137 Ligand Is Important for Type 1 Diabetes Development but Dispensable for the Homeostasis of Disease-Suppressive CD137+ FOXP3+ Regulatory CD4 T Cells," 2020, The Journal of Immunology

Frequent co-authors collaborating with Serreze include Jeremy J. Racine, Aron M. Geurts, Yi-Guang Chen, Harold D. Chapman, and Jennifer R. Dwyer.

The scientist regularly publishes in venues such as:

  • Faculty Opinions - Post-Publication Peer Review of the Biomedical Literature
  • The Journal of Immunology
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Science
  • Frontiers in Immunology

In addition to research articles, David V. Serreze has contributed to book publications, including a 2022 work titled Genetic Basis of Tolerance Induction Defects Underlying the Development of Autoimmune Pathologies, published by Frontiers Media.

Best Publications

  • Single domain antibodies: promising experimental and therapeutic tools in infection and immunity.

    Janusz Wesolowski;Vanina Alzogaray;Jan Reyelt;Mandy Unger

  • B lymphocytes are essential for the initiation of T cell-mediated autoimmune diabetes: analysis of a new "speed congenic" stock of NOD.Ig mu null mice.

    D V Serreze;H D Chapman;D S Varnum;M S Hanson

  • Interleukin 4 reverses T cell proliferative unresponsiveness and prevents the onset of diabetes in nonobese diabetic mice.

    M J Rapoport;A Jaramillo;D Zipris;A H Lazarus

  • B Lymphocytes Are Critical Antigen-Presenting Cells for the Initiation of T Cell-Mediated Autoimmune Diabetes in Nonobese Diabetic Mice

    David V. Serreze;Sara A. Fleming;Harold D. Chapman;Scott D. Richard

  • Defects in limb, craniofacial, and thymic development in Jagged2 mutant mice

    Rulang Jiang;Yu Lan;Harry D. Chapman;Carrie Shawber

  • Identification of the β cell antigen targeted by a prevalent population of pathogenic CD8+ T cells in autoimmune diabetes

    Scott M. Lieberman;Anne M. Evans;Bingye Han;Toshiyuki Takaki

  • Interleukin-2 gene variation impairs regulatory T cell function and causes autoimmunity

    Jun Yamanouchi;Dan Rainbow;Pau Serra;Sarah Howlett

  • TRPV1+ sensory neurons control beta cell stress and islet inflammation in autoimmune diabetes.

    Rozita Razavi;Yin Chan;F. Nikoo Afifiyan;Xue Jun Liu

  • Three recessive loci required for insulin-dependent diabetes in nonobese diabetic mice.

    Michal Prochazka;Edward H. Leiter;David V. Serreze;Douglas L. Coleman

  • Major Histocompatibility Complex Class I-Deficient NOD-B2mnull Mice are Diabetes and Insulitis Resistant

    David V Serreze;Edward H Leiter;Gregory J Christianson;Dale Greiner

  • Defects in the differentiation and function of antigen presenting cells in NOD/Lt mice.

    D V Serreze;H R Gaskins;E H Leiter

  • Major histocompatibility complex class I-restricted T cells are required for all but the end stages of diabetes development in nonobese diabetic mice and use a prevalent T cell receptor α chain gene rearrangement

    Teresa P. DiLorenzo;Robert T. Graser;Toshiro Ono;Toshiro Ono;Gregory J. Christianson

  • Defective activation of T suppressor cell function in nonobese diabetic mice. Potential relation to cytokine deficiencies.

    D V Serreze;E H Leiter

  • Acceleration of type 1 diabetes by a coxsackievirus infection requires a preexisting critical mass of autoreactive T-cells in pancreatic islets.

    David V. Serreze;Eric W. Ottendorfer;Tamir M. Ellis;Charles J. Gauntt

  • Mouse models for the study of autoimmune type 1 diabetes: a NOD to similarities and differences to human disease.

    John P. Driver;David V. Serreze;Yi-Guang Chen

  • Immunostimulation circumvents diabetes in NOD/Lt mice.

    David V. Serreze;Kazuyuki Hamaguchi;Edward H. Leiter

  • Hematopoietic stem-cell defects underlying abnormal macrophage development and maturation in NOD/Lt mice: defective regulation of cytokine receptors and protein kinase C

    David V. Serreze;Jens W. Gaedeke;Edward H. Leiter

  • The preferential ability of B lymphocytes to act as diabetogenic APC in NOD mice depends on expression of self-antigen-specific immunoglobulin receptors.

    Pablo A. Silveira;Ellis Johnson;Harold D. Chapman;Thi Bui

  • Use of recombinant congenic and congenic strains of NOD mice to identify a new insulin-dependent diabetes resistance gene.

    D V Serreze;M Prochazka;P C Reifsnyder;M M Bridgett

  • Identification of a CD8 T Cell That Can Independently Mediate Autoimmune Diabetes Development in the Complete Absence of CD4 T Cell Helper Functions

    Robert T. Graser;Teresa P. DiLorenzo;Fuming Wang;Gregory J. Christianson

  • Th1 to Th2 Cytokine Shifts in Nonobese Diabetic Mice: Sometimes an Outcome, Rather Than the Cause, of Diabetes Resistance Elicited by Immunostimulation

    David V. Serreze;Harold D. Chapman;Cristina M. Post;Ellis A. Johnson

Frequent Co-Authors

Edward H. Leiter
Edward H. Leiter The Jackson Laboratory
Dale L. Greiner
Dale L. Greiner University of Massachusetts Chan Medical School
Mark A. Atkinson
Mark A. Atkinson University of Florida
Leonard D. Shultz
Leonard D. Shultz Jackson Laboratory
Derry C. Roopenian
Derry C. Roopenian The Jackson Laboratory
Laurence B. Peterson
Laurence B. Peterson Roche (Switzerland)
Aldo A. Rossini
Aldo A. Rossini University of Massachusetts Chan Medical School
Pere Santamaria
Pere Santamaria University of Calgary
Linda S. Wicker
Linda S. Wicker University of Oxford
John P. Mordes
John P. Mordes University of Massachusetts Chan Medical School

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying immunology in the USA opens doors to a range of healthcare careers, often supported by various online degree programs. For those interested in entering the nursing field quickly, exploring accelerated nursing programs near me can provide a fast-track path to becoming a registered nurse.

Individuals seeking a more entry-level clinical role may find that easy lpn programs to get into offer practical training options with flexible online coursework, allowing a focus on immunology-related caregiving.

For advanced practice, easy nurse practitioner programs to get into enable students to deepen their expertise in patient care while maintaining a manageable study load. This can complement an immunology background by addressing immune-related diseases.

Mental health is another critical area where immunological insights are valuable. Programs like the best psychiatric mental health nurse practitioner programs online combine clinical training with a focus on psychiatric care, preparing graduates for roles at the intersection of neurology and immunology.

Best Scientists Citing David V. Serreze

Trending Scientists

Recently Published Articles